Osteoporosis Trial, Recruiting NCT07301749 Sponsor: Amber Implants B.V. Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07301749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 21 and 85 years old
  • You have a single spinal fracture caused by compression (not a burst or twisting injury) located in the mid or lower back area of the spine
  • Your fracture is either less than 6 weeks old, or imaging shows it may still be possible to correct the bone position
  • Imaging shows the affected vertebra has lost between 10% and 60% of its normal height at the front or middle section
  • The size and shape of the bones around the fracture are suitable for the device being used in this trial (confirm with trial site)
  • Your back pain rates at 5 or higher on a scale of 0 to 10
  • Your doctor believes surgery is the right option for you
  • Your Body Mass Index (BMI) is below 35
  • You are able to understand and follow the study requirements for its full duration
  • You are able to understand the risks and benefits and sign a written consent form

Who may not be able to join:

  • Your fracture involves a tumor spreading to the back of the spine, or there is a growth inside the spinal canal
  • Your fracture is older, has hardened, or cannot be repositioned (confirm with trial site)
  • You have a condition where one spinal bone has slipped significantly over another (more than a mild degree)
  • The angle of spinal curvature at the fracture site is greater than 30 degrees
  • You had a previous spinal fracture before the current one being treated
  • Your fracture requires surgery from the front of the spine to stabilize it
  • The fracture extends into the small bony bridges (pedicles) that connect parts of the vertebra
  • You have pressure on the spinal cord or spinal canal that needs to be surgically relieved
  • You have severe back pain rated above 5 out of 10 caused by something other than the fracture
  • You have been diagnosed with a slipped disc or severe narrowing of the spinal canal causing worsening weakness or paralysis
  • You need to take strong pain medications (opiates or opioids) every day due to another condition
  • You have existing nerve damage, nerve pain, or spinal cord problems before this fracture
  • You have uncontrolled diabetes (blood sugar levels remain very high), serious heart or lung problems, or another major health condition that could affect the study results
  • You are unable to have both an MRI scan and a bone scan
  • You are currently participating in another clinical trial that could affect this study's results
  • Your life expectancy is shorter than the length of this study, or you are receiving end-of-life care
  • You were unable to walk on your own before the fracture occurred
  • You have a known allergy to any materials used in the device or surgical instruments
  • You have an active infection of the spine or anywhere in your body, including an unresolved urinary tract infection
  • You have a bone disease other than osteoporosis (such as Paget's disease or brittle bone disease)
  • There is evidence of alcohol or drug misuse
  • You have been taking high-dose steroid medication (30 mg or more per day) for more than 3 months
  • You are currently receiving cancer treatment or HIV treatment
  • You are pregnant, or you could become pregnant and are unwilling to use contraception throughout the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 15 200 2151

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amber Implants B.V.
Registry
ClinicalTrials.gov
Start date
4 November 2025
Est. completion
31 July 2027

Where this trial is recruiting

🇫🇷 France 🇩🇪 Germany

Primary endpoints

Reduction of more than 2 points in vertebral fracture-related pain intensity at 6 months after the index procedure compared to baseline as measured by a 11-point Numerical Pain Rating Scale (NPRS); Maintenance or improvement of function as measured by the 100-point Oswestry Disability Index (ODI) at 6 months compared to baseline; Absence of serious adverse device effects (SADEs): No SADEs with causality rated as definite, monitored through 1 month post-procedure (safety)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov